These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9411241)

  • 1. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Dore GJ; Law MG; Kaldor JM
    N Engl J Med; 1997 Dec; 337(23):1697. PubMed ID: 9411241
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Aguado JM; Pulido F; Moreno S
    N Engl J Med; 1997 Dec; 337(23):1696-7; author reply 1697. PubMed ID: 9411240
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
    Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
    N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Desvarieux M
    N Engl J Med; 1998 Mar; 338(12):841; author reply 842-3. PubMed ID: 9508639
    [No Abstract]   [Full Text] [Related]  

  • 5. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Turner MT
    N Engl J Med; 1998 Mar; 338(12):841-2. PubMed ID: 9508640
    [No Abstract]   [Full Text] [Related]  

  • 6. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW; Morse MM; Pape JW; Johnson WD
    Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.
    Sacks HS
    Ann Intern Med; 2014 Sep; 161(6):JC12. PubMed ID: 25222412
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation.
    Eldred LJ; Churchyard G; Durovni B; Godfrey-Faussett P; Grant AD; Getahun H; Chaisson RE
    AIDS; 2010 Nov; 24 Suppl 5():S1-3. PubMed ID: 21079422
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive treatment for tuberculosis in people with HIV.
    Swaminathan S
    Lancet; 2014 Aug; 384(9944):644-6. PubMed ID: 24835843
    [No Abstract]   [Full Text] [Related]  

  • 12. Presumptive TB prophylaxis rejected.
    Torres G
    GMHC Treat Issues; 1997 Oct; 11(10):5-6. PubMed ID: 11364822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient?
    Rieder HL
    Clin Infect Dis; 2007 Jan; 44(1):103-4. PubMed ID: 17143824
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals.
    Saenghirunvattana S
    J Med Assoc Thai; 1996 May; 79(5):285-7. PubMed ID: 8708519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid prophylaxis against tuberculosis in children.
    Zar HJ; Lombard C
    N Engl J Med; 2011 Oct; 365(16):1543; author reply 1543-4. PubMed ID: 22010924
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis prophylaxis in HIV infection.
    Trevett A; Temu P; Naraqi S
    P N G Med J; 1993 Sep; 36(3):256. PubMed ID: 8059554
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of tuberculosis in HIV-infected patients.
    Nahid P; Daley CL
    Curr Opin Infect Dis; 2006 Apr; 19(2):189-93. PubMed ID: 16514345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.